Influenza B virus (ATCC® VR-787)

Classification: Orthomyxoviridae, Influenzavirus B  /  Product Format: frozen

Permits and Restrictions

View Permits

Classification Orthomyxoviridae, Influenzavirus B
Agent Influenza B virus
Strain B/R5
Applications
Influenza Research
Biosafety Level 2

Biosafety  classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Isolation
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786)
Product Format frozen
Storage Conditions -60°C or colder
Comments
Influenza strain B/Hong Kong/8/73 antigenicity, negative hemagglutinin thermosensitivity at 60C.
Effect on Host
Yes, in vitro effects: Hemagglutination activity
HA activity
Recommended Host
8 to 11 day chicken embryo, i.a. inoculation

Recommended Host:  CE (8-11 days, i.a.).

Host Range: CE

Host Range: CE

chicken embryo
Growth Conditions
Temperature: 37.0°C
Duration: 1-4 days
Effect on Host
Yes, in vitro effects: Hemagglutination activity
HA activity
Name of Depositor R.I.T. - Recherche et Industrie Therapeutiques
U.S. Patent Number
Source
Recombinant of B/Hong Kong/8/73 (ATCC VR-792) and influenza B/Brigit (ATCC VR-786)
References

Peetermans J, et al. Live influenza type B virus vaccines and preparation thereof. US Patent 3,962,423 dated Jun 8 1976

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation